脂质体布比卡因与局部镇痛混合液用于腹部皮瓣乳房再造腹横肌平面阻滞的比较
该回顾性研究纳入2015年11月至2019年12月间104例腹部自体乳房再造患者,比较腹横肌平面阻滞使用脂质体布比卡因(B组38例)与局部镇痛混合液(C组30例)及未行阻滞(A组36例)的术后阿片类药物用量。C组住院期间总每日口服吗啡当量(A组633、B组240、C组135,p<0.0001)和平均每日口服吗啡当量(A组137、B组56、C组29,p<0.0001)显著更低,门诊口服吗啡当量处方量也显著更少(A组79、B组74、C组52,p=0.01)。作者认为局部镇痛混合液可提供良好镇痛并减少术后阿片类药物使用。
要点
- C组住院总每日口服吗啡当量135显著低于A组633和B组240(p<0.0001)。
- C组住院平均每日口服吗啡当量29显著低于A组137和B组56(p<0.0001)。
- C组门诊口服吗啡当量处方量52显著少于A组79和B组74(p=0.01)。
核心结论
- 局部镇痛混合液(布比卡因、酮咯酸、右美托咪定和地塞米松)用于腹横肌平面阻滞可提供良好镇痛并减少术后阿片类药物使用。
- 脂质体布比卡因是腹横肌平面阻滞的常用选择,但局部镇痛混合液由经济易得的药物组成。
研究设计与样本
- 回顾性研究,纳入2015年11月至2019年12月间接受腹部自体乳房再造的患者104例。
- A组36例(ERAS前、未行腹横肌平面阻滞),B组38例(ERAS、腹横肌平面阻滞使用脂质体布比卡因),C组30例(ERAS、腹横肌平面阻滞使用局部镇痛混合液)。
- 研究组(C组)使用布比卡因、酮咯酸、右美托咪定和地塞米松;对照组(B组)使用脂质体布比卡因,联用或不联用布比卡因、酮咯酸或右美托咪定。
- 主要结局为术后阿片类药物使用和疼痛评分。
- 证据等级:治疗性,III级。
主要发现
- 住院期间总每日口服吗啡当量:A组633、B组240、C组135,C组显著低于A组和B组(p<0.0001)。
- 住院期间平均每日口服吗啡当量:A组137、B组56、C组29,C组显著低于A组和B组(p<0.0001)。
- 门诊口服吗啡当量处方量:A组79、B组74、C组52,C组显著少于A组和B组(p=0.01)。
关键数值与推荐
- 住院总每日口服吗啡当量:A组633、B组240、C组135(p<0.0001)。
- 住院平均每日口服吗啡当量:A组137、B组56、C组29(p<0.0001)。
- 门诊口服吗啡当量处方量:A组79、B组74、C组52(p=0.01)。
临床怎么用
- 腹横肌平面阻滞是腹部乳房再造ERAS方案的重要组成部分。
- 作者的结果表明,由经济易得药物组成的局部镇痛混合液可提供良好镇痛并减少术后阿片类药物使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transversus abdominis plane blocks can improve pain control and decrease opioid use within an enhanced recovery after surgery (ERAS) protocol in patients undergoing abdominally based autologous breast reconstruction. The authors have transitioned to using a local analgesic cocktail for transversus abdominis plane blocks. The purpose of this study was to compare postoperative opioid use in patients who received the blocks. METHODS: Patients who underwent abdominally based autologous breast reconstruction between November of 2015 and December of 2019 were retrospectively reviewed. The study group received bupivacaine, ketorolac, dexmedetomidine, and dexamethasone; the control group received liposomal bupivacaine with or without bupivacaine, ketorolac, or dexmedetomidine, as a transversus abdominis plane block. The primary outcome of interest was postoperative opioid use and pain scores. RESULTS: One hundred four women met inclusion criteria: 36 in group A (before ERAS, before transversus abdominis plane block), 38 in group B (ERAS, transversus abdominis plane block with liposomal bupivacaine), and 30 in group C (ERAS, transversus abdominis plane block with local anesthetic cocktail). Total daily oral morphine equivalent consumption (group A, 633; group B, 240; group C, 135; p < 0.0001) and average daily oral morphine equivalent consumption (group A, 137; group B, 56; group C, 29; p < 0.0001) were significantly less for group C in the inpatient phase. Patients in group C were prescribed significantly fewer outpatient oral morphine equivalents (group A, 79; group B, 74; group C, 52; p = 0.01). CONCLUSIONS: Transversus abdominis plane blocks are a significant component of an ERAS protocol for abdominally based breast reconstruction. Liposomal bupivacaine is a popular option for transversus abdominis plane blocks. The authors' results demonstrate that a local anesthetic cocktail, composed of economical and readily available medications, can provide excellent patient pain control and decrease postoperative opioid use. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Lombana NF, Falola RA, Zolfaghari K, et al. Comparison of Liposomal Bupivacaine to a Local Analgesic Cocktail for Transversus Abdominis Plane Blocks in Abdominally Based Microvascular Breast Reconstruction. Plast Reconstr Surg. 2022. PMID: 35749219. doi:10.1097/PRS.0000000000009398
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。